Beauty Farm Medical and Health Industry Inc. disclosed that it bought back 12,000 ordinary shares on 15 July 2026 via on-market transactions on the Hong Kong Stock Exchange.
The repurchase was executed at prices between HK$17.52 and HK$17.81 per share, producing a volume-weighted average cost of HK$17.6542 and an aggregate consideration of HK$0.21 million. All repurchased shares have been retained as treasury shares.
Following the transaction, the company’s outstanding share count (excluding treasury shares) fell by 0.0048 % to 248.17 million, while treasury shares rose to 3.43 million. Total issued shares remained unchanged at 251.59 million.
The buyback forms part of the repurchase mandate approved on 26 June 2026, which authorises Beauty Farm to repurchase up to 24.85 million shares. Cumulative repurchases under this mandate now stand at 352,500 shares, representing 0.14 % of the company’s issued share capital at the mandate date.
In accordance with Hong Kong listing rules, Beauty Farm is subject to a moratorium on issuing new shares or disposing of treasury shares until 14 August 2026.
Comments